1-3 of 3
Yuliya Kreychman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Experience with Combination Therapy of Fostamatinib and Thrombopoetin Receptor Agonists (TPO-RAs) for Treatment of Immune Thrombocytopenia (ITP): Patient-Reported Outcomes

Elizabeth Bowhay-Carnes, Yuliya Kreychman, Lucas Buxman, Leslie Todd
Journal: Blood
Blood (2024) 144 (Supplement 1): 5080.
https://doi.org/10.1182/blood-2024-204078
Published: 2024
Journal Articles

The Safety and Efficacy of Fostamatinib in Patients with Chronic Immune Thrombocytopenic Purpura Treated in a Real-World Community Hematology Setting

Mehdi M. Moezi, Aaron Peevyhouse, Tiffany Wood, Yuliya Kreychman, George Dranitsaris
Journal: Blood
Blood (2022) 140 (Supplement 1): 5135–5136.
https://doi.org/10.1182/blood-2022-170529
Published: 2022
Journal Articles

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

Ralph Boccia, MD, Michael A. Boxer, MD, Waleed Ghanima, MD PhD, Quentin A. Hill, Michelle Sholzberg, MDBSc,FRCPC,MSc, Michael D. Tarantino, MD, Yuliya Kreychman, PharmD, Robert P. Numerof, PhD, Brian Olender, BA, Leslie Todd, Sandy Tong, MD, Anne-Marie Duliege, MDMS, Nichola Cooper, MD MRCP, James B. Bussel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1069.
https://doi.org/10.1182/blood-2019-126473
Published: 2019